A clinically approved copper chelator in combination with standard-of-care chemotherapy reduces tumour desmoplasia and metastasis in PDAC (#215)
Ellie T.Y. Mok
1
2
,
Yordanos F.I. Setargew
1
,
Joanna N. Skhinas
1
,
Michelle Yam
1
,
Ron Enriquez
1
,
Emmi Tran
1
,
Dasol Yoo
1
,
Céline Schmitter
1
3
,
Sipiththa Velayuthar
1
,
Kaitlin Wyllie
1
2
,
Jessica L. Chitty
1
2
,
Thomas R. Cox
1
2
- Cancer Ecosystems Program, The Garvan Institute of Medical Research & the Kinghorn Cancer Centre, Sydney, NSW, Australia
- School of Clinical Medicine, St Vincent’s Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia
- Current Address: Biology Department, École Normale Supérieure of Lyon, Claude Bernard Lyon 1 University, University of Lyon, Lyon, France